ATE527267T1 - 1-ä2',3'-didesoxy-3'-c(hydroxymethyl)-b-d-eryth o-pentofuranosylü cytosinderivate als hiv- inhibitoren - Google Patents

1-ä2',3'-didesoxy-3'-c(hydroxymethyl)-b-d-eryth o-pentofuranosylü cytosinderivate als hiv- inhibitoren

Info

Publication number
ATE527267T1
ATE527267T1 AT06777595T AT06777595T ATE527267T1 AT E527267 T1 ATE527267 T1 AT E527267T1 AT 06777595 T AT06777595 T AT 06777595T AT 06777595 T AT06777595 T AT 06777595T AT E527267 T1 ATE527267 T1 AT E527267T1
Authority
AT
Austria
Prior art keywords
pentofuranosylü
didesoxy
eryth
hydroxymethyl
hiv inhibitors
Prior art date
Application number
AT06777595T
Other languages
English (en)
Inventor
Xiao-Xiong Zhou
Christer Sahlberg
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Application granted granted Critical
Publication of ATE527267T1 publication Critical patent/ATE527267T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT06777595T 2005-07-07 2006-07-05 1-ä2',3'-didesoxy-3'-c(hydroxymethyl)-b-d-eryth o-pentofuranosylü cytosinderivate als hiv- inhibitoren ATE527267T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0513835.9A GB0513835D0 (en) 2005-07-07 2005-07-07 HIV inhibitors
PCT/EP2006/063919 WO2007006707A1 (en) 2005-07-07 2006-07-05 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors

Publications (1)

Publication Number Publication Date
ATE527267T1 true ATE527267T1 (de) 2011-10-15

Family

ID=34856749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06777595T ATE527267T1 (de) 2005-07-07 2006-07-05 1-ä2',3'-didesoxy-3'-c(hydroxymethyl)-b-d-eryth o-pentofuranosylü cytosinderivate als hiv- inhibitoren

Country Status (18)

Country Link
US (2) US7888367B2 (de)
EP (2) EP1899352B1 (de)
JP (1) JP5174660B2 (de)
CN (1) CN101213198B (de)
AT (1) ATE527267T1 (de)
AU (1) AU2006268743C1 (de)
BR (1) BRPI0612678A2 (de)
CA (1) CA2610210A1 (de)
CY (1) CY1112164T1 (de)
DK (1) DK1899352T3 (de)
ES (1) ES2373743T3 (de)
GB (1) GB0513835D0 (de)
HR (1) HRP20110830T1 (de)
MX (1) MX2008000221A (de)
PL (1) PL1899352T3 (de)
PT (1) PT1899352E (de)
WO (1) WO2007006707A1 (de)
ZA (1) ZA200710662B (de)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810907D0 (en) 1988-05-09 1988-06-15 British Telecomm Fluoride glass optical coupler & method of manufacture
ZA902631B (en) * 1989-04-06 1990-12-28 Bristol Myers Squibb Co 3'-substituted methyl nucleosides as antiviral agents
US5866775A (en) 1990-09-28 1999-02-02 Monsanto Company Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
US5612319A (en) 1994-05-31 1997-03-18 Medivir Ab Postexposure prevention of HIV infection or seroconversion
AU697612B2 (en) * 1994-05-31 1998-10-15 Medivir Ab Post exposure prevention of HIV
PT988304E (pt) 1997-08-15 2001-10-31 Medivir Ab Analogos de nucleosidos tais como os antivirais que contem inibidores de transcritase reversa retroviral e de adn-polimerase do virus da hepatite b (hbv)
EP1964569A3 (de) * 2000-04-13 2009-07-22 Pharmasset, Inc. 3'- oder 2'-Hydroxymethyl-substituierte Nukleosidderivate zur Behandlung von Virusinfektionen
US7109931B2 (en) 2004-06-18 2006-09-19 Centurion Wireless Technologies, Inc. Method and apparatus to control an antenna efficiency test device
ES2325088T3 (es) * 2004-12-30 2009-08-25 Medivir Ab Compuestos utiles en el tratamiento de hiv.

Also Published As

Publication number Publication date
CN101213198A (zh) 2008-07-02
EP1899352B1 (de) 2011-10-05
EP1899352A1 (de) 2008-03-19
US8143396B2 (en) 2012-03-27
HK1122798A1 (en) 2009-05-29
ZA200710662B (en) 2008-11-26
MX2008000221A (es) 2008-03-18
WO2007006707A1 (en) 2007-01-18
DK1899352T3 (da) 2012-01-30
HRP20110830T1 (hr) 2011-12-31
AU2006268743C1 (en) 2010-12-16
BRPI0612678A2 (pt) 2010-11-30
CA2610210A1 (en) 2007-01-18
US20080221140A1 (en) 2008-09-11
PT1899352E (pt) 2012-01-05
JP2008545002A (ja) 2008-12-11
US20110112294A1 (en) 2011-05-12
JP5174660B2 (ja) 2013-04-03
GB0513835D0 (en) 2005-08-10
AU2006268743A1 (en) 2007-01-18
AU2006268743B2 (en) 2010-07-29
EP2336135A3 (de) 2011-07-27
CY1112164T1 (el) 2015-12-09
PL1899352T3 (pl) 2012-03-30
ES2373743T3 (es) 2012-02-08
CN101213198B (zh) 2011-08-03
US7888367B2 (en) 2011-02-15
EP2336135A2 (de) 2011-06-22

Similar Documents

Publication Publication Date Title
CY1106801T1 (el) Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
CY1111143T1 (el) Καινοφανη παραγωγα κυανοπυριδινης χρησιμα στην αντιμετωπιση καρκινου και αλλων διαταραχων
ATE302775T1 (de) Carbolinderivate
DK1487444T3 (da) Anvendelse af pyridylamider som angiogeneseinhibitorer
CY1119077T1 (el) Παραγωγα πυραζολυλαμινοπυριδινης χρησιμα ως αναστολεις κινασων
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
CY1113858T1 (el) Παραγωγα πυριδιν-3-υλιου ως ανοσορυθμιστικοι παραγοντες
MA29136B1 (fr) Agents de potentialisation de recepteurs du glutamate
EA201000050A1 (ru) Замещенные бициклолактамные соединения
UY30310A1 (es) Derivados 2-azetidinona, sales, solvatos, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
ATE513842T1 (de) Neue dihydropseudoerythromycinderivate
CY1111701T1 (el) Υδροχλωρικο αλας του 5-[3-(3-υδροξυφαινοξυ)αζετιδιν-1-υλ]-5-μεθυλ-2,2-διφαινυλεξαναμιδιου
NO20052908L (no) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
ATE479693T1 (de) Phosphoindole als hiv-inhibitoren
BR0200536A (pt) Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase
EA200602281A1 (ru) Гетероарилсульфоны и сульфонамиды и их терапевтические применения
EP2183256A4 (de) Therapeutische verbindungen
BRPI0607214A2 (pt) derivados de 2-(4-cianofenilamino) pirimidina inibidores de hiv
BRPI0411208A (pt) uso de derivados 2-amino-1,3-propanodiol para a fabricação de um medicamento para o tratamento de vários tipos de dor
ATE527267T1 (de) 1-ä2',3'-didesoxy-3'-c(hydroxymethyl)-b-d-eryth o-pentofuranosylü cytosinderivate als hiv- inhibitoren
CY1108241T1 (el) Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας
SE0102058D0 (sv) New Salts II

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties